Woman fled America because of allergies: This is how foreign diets affected her body
O
ut of all the imaginable reasons one would be forced to leave America, a woman revealed that her allergies were hers. However, her body saw shocking changes once she moved abroad.
For three years, Bee, who uses the diminutive moniker online, had suffered numerous instances of anaphylaxis, hives and stomach aches triggered by the kind of food Americans love, such as cheese, wheat breads and even fresh produce.
'I didn't want to leave behind my entire life in the US, but I didn't feel like I had a choice,' she said of moving to Europe in November 2024, per Newsweek. 'I had to, I felt like my body was slowly shutting down from lack of nutrition because my diet was so limited.'
Her diet consists of three foods: broccoli, coconut and chicken.
'Welcome to my series where I test foods that normally give me … histamine reactions in America outside of America to see if I get the same reaction,' she told viewers of her TikTok page, where she documents the changes in her diet and body. She added how she was bracing for the worst after consuming one of her trigger foods in another country, but surprisingly, the reaction never came.
Thus, she began a quest of trying every food that used to make her sick and allergic in the US, such as pizza, French fries and pasta.
The woman revealed that she was suffering from mast cell activation syndrome (MCAS), an allergy-adjacent condition that can develop out of the blue.
MCAS is a condition in which toxins or pathogens cause the immune cells to over-produce chemicals to combat the invader, leading to symptoms such as itching, flushing, hives, abdominal pain, diarrhea, low blood pressure, dizziness and brain fog.
Bee's MCAS were triggered from food-based mycotoxins, which she confirmed with a battery of medical tests.
In a recent video, she tried eating breaded shrimp at a Thai restaurant. The video received nearly 2.1 million views on TikTok, including that of TikTok's famous allergist, Dr. Rubin.
In a post with Bee, he warned people against trying new food without medical supervision. 'You should not be going to another country to try foods if you were prescribed epinephrine because food allergies can be potentially life-threatening.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
21 minutes ago
- Time of India
This habit with smoking can increase your chances of oral cancer by 624% in the next 5 years
Image credits: Getty Images Smoking leaves behind more than just a taste in your mouth; it leaves behind an elevated risk of oral cancer. In the media, a theory called Cognitive Dissonance is taught to students. It focuses on the discomfort felt when holding conflicting beliefs, leading to people justifying their behaviour. When it comes to smoking, the theory is applied unknowingly by every person addicted to the habit, where they are well aware of the risks and damages it can cause, but keep on justifying the habit with reasons. While this may seem harmless, it can be fatal. Not only smoking, a new study out of YC San Diego suggests that a chronic weed habit can also lead to a high risk of oral cancer. People who often smoke marijuana are 3.25 times likely to contract the disease within 5 years when compared to those without the cannabis use disorder. 'Cannabis smoke contains many of the same carcinogenic compounds found in tobacco smoke, which have known damaging effects on the epithelial tissue that lines the mouth,' said Raphael Cuomo, an associate professor in the Department of Anesthesiology at UC San Diego School of Medicine and member of UC San Diego Moores Cancer Center, to the NY Post. According to the American Cancer Society, nearly 60,000 new cases of oral cavity or oropharyngeal cancer AND ABOUT 12,800 deaths have been reported in the US this year. Oral cancer includes cancer in the lips, tongue, gums and lining of the cheeks and the mouth. The common risk factors of the disease include tobacco use, chronic alcohol addiction and human papillomavirus (HPV) infection. The increasing risk of oral cancer Image credits: Getty Images The researchers analysed health data from over 45,000 oral cancer patients, including 949 who had been previously diagnosed with cannabis use disorder. They accounted for the factors of age, sex, body mass index and smoking status. They revealed that tobacco smokers with a cannabis addiction are 624% more likely to get oral cancer within 5 years, compared to cigarette users who don't smoke marijuana. The inhaled smoke, as per researchers, damages the mouth tissues and causes cancer. 'Research is still evolving, so regular self-checks and dental exams remain wise for all cannabis users,' said Cuomo. Along with this study, a 2024 study from the University of Southern California also linked marijuana consumption to a 3-5 5-fold increase in the risk of head and neck cancers, of which oral cancer is a type. Cuomo suggested seeing a dentist or an ENT specialist if one has a sore, ulcer, red or white patch in the mouth that has lasted for more than two weeks. 'Early evaluation is critical because oral cancers caught in the first stage are usually curable,' he said.
Hindustan Times
3 hours ago
- Hindustan Times
Early immunisation critical in preventing RSV in infants
Respiratory illnesses in newborns are a major cause of concern, especially when they involve difficulty in breathing. Among the leading causes is Respiratory Syncytial Virus (RSV), a common and highly severe virus that affects the lungs and airways of infants and children under five. This virus often mimics symptoms of a common cold, such as a runny nose or low-grade fever. This similarity can create confusion for parents and health care providers alike, leading to delays in detection and intervention, which allows the illness to rapidly escalate. Vaccination (Getty Images/iStockphoto) For newborns and infants, whose immune systems are still developing, and airways are small, RSV can quickly become serious. Their tiny airways can get easily blocked by swelling and mucus, leading to lung infections like bronchiolitis or pneumonia. Each year, RSV leads to over 3.6 million hospitalisations and about 100 000 deaths in children under five years of age. As per WHO, most paediatric RSV deaths (97%) occur in low- and middle-income countries where there is limited access to supportive medical care. Even healthy, full-term babies can face complications, and in some cases, require intensive medical care. In India, RSV cases spike during the monsoon and early winter, but the virus can circulate throughout the year. This makes timely protection critical. Medical advancements now offer a way to shield infants through immunisation strategies. While the RSVpreF maternal vaccine is not yet available in India, two monoclonal antibodies have emerged as key preventive options in India. Palivizumab, is administered monthly to high-risk infants such as those born prematurely or with underlying heart or lung conditions. Nirsevimab, on the other hand, is a long-acting monoclonal antibody offering protection with a single-dose. It is designed for all infants regardless of risk category and can be administered soon after birth, before hospital discharge, or during early routine check-ups. Early immunization plays a vital role in protecting infants not just from immediate illness, but also from long-term respiratory complications. Severe RSV infections in the first year of life have been linked to increased risk of recurrent wheezing, asthma, ear infections, and reduced lung function well into adolescence. Infants are especially vulnerable because their immune systems are still developing, and their smaller airways are more easily blocked by inflammation caused by the virus. By providing protection before exposure, through timely use of preventive monoclonal antibodies, we are better equipped to avoid serious outcomes for babies. Parents must understand the importance of stopping the virus before it can take hold, reducing the likelihood of hospitalisation and long-term health issues. For parents and health care providers alike, early immunisation isn't just a seasonal precaution, it's a critical investment in the child's long-term respiratory health and overall well-being. This article is authored by Dr Faisal B Nahdi, paediatrician, Rainbow Children's Hospital, Hyderabad.
Hindustan Times
3 hours ago
- Hindustan Times
What are chikungunya symptoms? CDC issues travel warning for China amid outbreak
Americans travelling to China have been advised to practice utmost caution in the wake of the chikungunya virus outbreak in the country. A Level 2 travel alert was issued by the US Centers for Disease Control and Prevention (CDC) in this regard last week. CDC issued warning for Americans traveling to China after the Chikungunya outbreak.(Unsplash) This comes as more than 7,000 cases of the mosquito-borne virus were reported in the Guangdong province of China, forcing the authorities to put in measures similar to the ones taken during the COVID-19 pandemic period, as per BBC. Among the worst-affected regions in the country is the city of Foshan, where chikungunya patients have been ordered to stay in the hospital until they test negative. They will be discharged at the end of a week-long stay, and their beds are being protected using mosquito nets. Chikungunya: What to know? The viral disease is transmitted mainly through the Aedes mosquitoes. It is caused by the chikungunya virus (CHIKV), which is an RNA virus in the alphavirus genus of the Togaviridae family, as per the World Health Organization (WHO). CHIKV was identified for the first time in the United Republic of Tanzania in 1952, while major outbreaks have been reported in America, Asia, and Africa. A study that came out in Nature in June this year, estimated that around 35.3 million people get infected by Chikungunya on an annual basis across 180 countries and regions. It leads to nearly 3,700 deaths, which is 0.01% of the total cases, as per TIME magazine. The latest outbreak in China has been attributed to imported cases. Liu Qiyong, China CDC's chief expert in vector-borne disease control, told CGTN, 'With the virus spreading globally, imported cases have inevitably reached China.' Chikungunya symptoms The WHO states that chikungunya symptoms are quite similar to dengue and Zika, thus making it difficult to diagnose the disease and accurately determine the total number of infected persons. Also read: Chikungunya outbreak: China on high alert as Guangdong battles over 7,000 cases amid COVID like strict measures Some of the most common symptoms of Chikungunya include high fever, joint pain, headache, muscle pain, as well as joint swelling and rashes. The symptoms usually appear around 4-8 days after the patient is bitten by the infected mosquito. At first, the person gets to witness an 'abrupt onset of fever, frequently accompanied by severe joint pain,' as per the WHO. Notably, the joint pain is often debilitating and can last anywhere from a few days to weeks, months, and even years in some cases. While most of the patients completely recover from the infection, there are cases of eye, heart, and neurological complications that have come up due to the CHIKV infection. FAQs: 1. Why CDC has issued a warning for China? CDC's Level 2 alert, which is designated as 'Practice Enhanced Precautions', came out after China marked over 7,000 cases of chikungunya infections. 2. How are chikungunya patients treated? No specific antiviral treatment is available for the chikungunya virus infections. Usually, doctors give antipyretic and analgesic medications, like paracetamol, for fever and pain, as per the WHO. Also, there are two chikungunya vaccines that have received regulatory approvals, but these are not widely available. 3. Is chikungunya fatal? Severe symptoms and deaths from the viral disease are rare, occurring mostly among young children or elderly people who have co-existing health problems.
